What Does It Cover?
Single molecule counting (SMC®) technology enables accurate measurement of molecules at levels previously undetectable allowing researchers to identify new biomarkers, or assist in therapeutic development with an improved view of efficacy, safety & time course studies. Combining a traditional immunoassay workflow with patented SMC® technology enables the detection of low-abundance biomarkers, such as proteins and nucleic acids, with unparalleled sensitivity and accuracy, capturing concentrations down to the femtogram/mL level. You will learn how to detect, and monitor changes in, extremely low levels of established disease biomarkers such as cardiac troponin I and cytokines.
What Will You Learn?
- General background on Single Molecule Counting (SMC®) technology
- How SMC® technology enables quantification of low concentration biomarkers for improved stratification of sample populations, drug development and new biomarker discovery
- How to build your own bead-based or plate-based
Who Should Attend?
- Researchers interested in biomarker discovery
- Therapeutic development scientists
- Protein biochemists
- Life science researchers
- Molecular biologists
Speakers
Anitaben Tailor, Ph.D.
Merck
Biology Technical Marketing
Anitaben Tailor brings over 10 years of immunoassay platform experience in the biopharmaceutical industry. After her post-doctoral fellowship, she held faculty positions at Johns Hopkins and NIH; then joined the industry in a global role with Merck's Life Science division. More recently, she focuses on the technical marketing of the Immunoassay portfolio within Pharma and CROs.
Research and disease areas
- Immunology research
期間:48min
言語:English
セッション 1:presented May 9, 2018
続きを確認するには、ログインするか、新規登録が必要です。
アカウントをお持ちではありませんか？